3 New Weight Loss Medicine Waiting for FDA Approvel
Food and Drug Administration has been very busy this entire week to analyze and test the first of three new weight loss drug awaiting approval. Qnexa, manufactured by Vivus, Inc., is the first drug awaiting FDA approval.
Qnexa is almost the same weight loss drugs in the past. The main components of the drug is still present: the combination of an anticonvulsant and amphetamines. There are a lot of side effects associated with this combination of drugs. FDA will evaluate whether this is acceptable to counter what they see as an epidemic of obesity.
With a lot of diabetes medicine Avandia now get most of the limelight at the moment, not much new has been focused on these new drugs. FDA must decide the Weight Loss actually occurs and whether the health benefits are greater than the risks to health.
As of now, there has been much pioneering developments in diet aids from pharmaceutical companies. They have been slow to provide the resolution to real problems that cause obesity, and are based on the opinion that it’s all because of the discipline to eat. The last two main products, which are designed to remove excess food has been recalled from the market when the first drug combination caused heart damage and failure, and the other drug has caused fatal bleeding in the brain. The FDA has always warned consumers to use all types of drugs with caution pending the results show the real world if the product is good. Results like those that exist with regard to Avandia, which was praised by the FDA and is now responsible for over 100,000 deaths in various parts of the globe.
Processing your request, Please wait....
